Literature DB >> 2177203

Structure-activity relationships in DNA gyrase inhibitors.

S Rádl1.   

Abstract

The review brings the status of research into DNA gyrase inhibitors up to date. Structure-activity relationships in both coumarin antibiotics, like novobiocin or coumermycins, and quinolones are discussed. In the section dealing with the quinolones, promising drugs under further evaluation are pointed out. Recently discovered new types of DNA gyrase inhibitors, i.e. tetramic acid derivatives and biphenyl dicarboxylic acid monoamides, are also briefly mentioned.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177203     DOI: 10.1016/0163-7258(90)90014-s

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  6 in total

1.  DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs.

Authors:  M E Cove; A P Tingey; A Maxwell
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

2.  Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase.

Authors:  M Oram; B Dosanjh; N A Gormley; C V Smith; L M Fisher; A Maxwell; K Duncan
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

3.  GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.

Authors:  M Stieger; P Angehrn; B Wohlgensinger; H Gmünder
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

4.  Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase.

Authors:  A P Tingey; A Maxwell
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

5.  Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting.

Authors:  G Orphanides; A Maxwell
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

6.  Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.

Authors:  D S Samuels; C F Garon
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.